European stock markets traded mixed on Monday as renewed uncertainty over U.S. trade tariffs dampened investor sentiment, while Novo Nordisk shares plunged following disappointing obesity drug trial results. Germany’s DAX fell 0.5% to lead regional losses, the UK’s FTSE 100 edged down 0.1%, and France’s CAC 40 managed a modest 0.1% gain in early trading.
Global equities initially rallied after the U.S. Supreme Court invalidated most of former President Donald Trump’s previously imposed tariffs, ruling that the emergency law used did not authorize such measures. However, Trump quickly introduced a new global tariff plan over the weekend, announcing levies of 10% to 15% that could remain in place for up to five months. The sudden policy shift reignited concerns about trade stability and weighed on overall risk appetite. European Central Bank President Christine Lagarde emphasized the importance of predictable trade rules, noting that uncertainty can disrupt global investment and economic equilibrium.
Recent economic data had supported optimism across Europe. The STOXX 600 index reached record highs last week as Eurozone business activity accelerated faster than expected. Manufacturing returned to growth territory for the first time since October, and Germany’s Ifo business climate index climbed to 88.6 in February, signaling early signs of economic recovery in Europe’s largest economy.
In corporate news, Novo Nordisk stock dropped more than 10% after its experimental obesity treatment CagriSema failed to meet a primary endpoint in a head-to-head trial against Eli Lilly’s Tirzepatide. The setback intensifies competition in the rapidly expanding weight-loss drug market, where Novo’s Wegovy and Ozempic previously dominated.
Meanwhile, oil prices retreated ahead of a third round of U.S.-Iran nuclear talks in Geneva. Brent crude slipped to $70.96 per barrel, while West Texas Intermediate fell to $66.15, as hopes for a diplomatic breakthrough eased supply disruption concerns.


Asian Currencies Stabilize as Dollar Holds Near Two-Month High After Fed Hawkish Signal
Asian Stocks Surge as Oil Prices Fall and Strong US Dollar Weighs on Markets
Oil Prices Drop as U.S.-Iran Peace Deal Eases Supply Concerns
Dollar Surges After Fed Holds Rates Steady, Signals Potential Tightening Ahead
Asian Stocks Advance as Nikkei Nears Record High Ahead of Fed Decision
US Stock Futures Jump on Reports of Preliminary US-Iran Peace Deal Despite Fed’s Hawkish Outlook
Asian Currencies Steady as Dollar Holds Firm Ahead of Fed Decision and US-Iran Deal Details
Trump Questions USMCA Renewal as Trade Talks Continue
Oil Prices Slide as U.S.-Iran Deal and Hormuz Reopening Ease Supply Concerns
Italy’s Economy Outpaces Eurozone Peers as Investment Spending Fuels Growth
Asian Stocks Rally as Japan and South Korea Reach Record Highs on US-Iran Peace Deal
ASX Proposes New Share Dilution Limits for Public Takeovers
Japan Inflation Stays Below BOJ Target Despite Rate Hike and Rising Energy Cost Risks
Dollar Hits One-Month High as Hawkish Fed Outlook Boosts Greenback
German Auto Suppliers Turn Bearish as Investment and Jobs Shift Overseas
Europe EV Demand Surges as Fuel Prices Rise Amid Iran Conflict
Oil Prices Steady as U.S.-Iran Truce Uncertainty and Middle East Tensions Keep Markets on Edge 



